Altre lingue Parmax Pharma Limited

Azioni

PARMAX6

INE240T01014

Tempo differito Bombay S.E. Altri mercati azionari 06:14:24 12/07/2024			Variaz. 5gg	Var. 1 gen.
35,8 ^INR	+4,16%		+15,90%	+9,92%

02/05	Parmax Pharma Limited nomina Bhakti Aghera come Segretario aziendale e Responsabile della conformità, con effetto dal 02 maggio 2024	CI
31/01	Parmax Pharma Limited annuncia le dimissioni di Yash Vora da Segretario aziendale e Compliance Officer	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Parmax Pharma Limited Appoints Bhakti Aghera as Company Secretary and Compliance Officer, Effective from May 02, 2024	02/05
Parmax Pharma Limited Announces the Resignation of Yash Vora as Company Secretary & Compliance Officer	31/01
Parmax Pharma Limited Announces Resignation of Mr. Pramay Amritlal Chhatra as Director	27/04/23
Parmax Pharma Limited Announces Resignation of Nikhil Uchat as Independent Director	25/04/23
Parmax Pharma Limited Announces Demise of Asha Daftary, Independent Director	27/09/21
Parmax Pharma Limited Announces Unaudited Standalone Earnings Results for the First Quarter Ended 30 June, 2021	14/08/21
Parmax Pharma Limited Reports Audited Standalone Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2021	14/08/21
Parmax Pharma : Managing Director Passes Away	15/04/21
Parmax Pharma Limited Announces Sad Demise of Shri Alkeshbhai Gosalia, Managing Director	15/04/21
Parmax Pharma Limited cancelled the transaction announced on January 16, 2021	20/02/21
Parmax Pharma Limited Approves Resignation of Alkesh Gopani from the Post of Managing Director	12/02/21
Parmax Pharma Limited Approves Board Resignations	12/02/21
Parmax Pharma Limited Announces Unaudited Standalone Earnings Results for the Third Quarter and Nine Months Ended December 31, 2020	12/02/21
Parmax Pharma Limited Announces Board Changes	04/02/21
Parmax Pharma Limited Announces Resignation of Alkesh Gopani as Managing Director, Effective February 8, 2021	04/02/21
Parmax Pharma Limited announced a financing transaction	16/01/21
Parmax Pharma Limited Announces Temporary Closure of its Manufacturing Unit	25/08/20
Parmax Pharma Limited Announces Unaudited Standalone Earnings Results for the Third Quarter and Nine Months Ended December 31, 2019	13/02/20
Parmax Pharma Limited Appoints Alkesh R. Gosalia as Managing Director (Finance and Operations)	27/09/19
Parmax Pharma Limited Announces Unaudited Standalone Earnings Results for the First Quarter Ended 30 June, 2019	09/08/19

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Parmax Pharma Limited

Azioni

PARMAX6

INE240T01014

Altre lingue

Filtri